Frequently Asked Questions
Answers to common queries to help you use and access MIMS.
General MIMS queries
|MIMS, or the Monthly Index of Medical Specialities, is the essential prescribing reference for general practice. MIMS has been providing healthcare professionals with information on prescription medicines since 1959.
|MIMS provides concise summaries of prescribing information for branded and generic products that can be prescribed in the UK, including devices listed in parts IXA and IXR of the Drug Tariff. Drugs that are blacklisted (ie, not prescribable on the NHS) are not listed and no information is given on the unlicensed or off-label use of drugs.
|MIMS also includes prescribing news, drug reference tables, travel vaccination and malaria prophylaxis recommendations, at-a-glance summaries of national treatment guidance and NICE drug appraisals, and visual guides to diabetes and respiratory devices. Further resources, including patient fact sheets, clinical calculators and prescribing resource centres for specific disease areas, are available online at mims.co.uk .
|MIMS is available in quarterly print issues, online at mims.co.uk and as a mobile app for iPhone, iPad and Android. Paid subscriptions include both print and online access.
|MIMS is one of the most up-to-date prescribing references for healthcare professionals.
|Online, mims.co.uk is updated constantly, with changes to the drug information and prescribing news published throughout each working day.
|In print, MIMS is published every quarter, in March, June, September and December. Each quarterly print edition includes all the updates from the corresponding three months of online updates.
|MIMS offers three bulletins to help you keep abreast of important developments in medicines and prescribing:
- MIMS Prescribing Update - a summary of the latest news sent to you twice a month
Sign up at mims.co.uk/bulletins
- MIMS Spotlight - a regular round-up of key prescribing news and resources, each issue focussing on a different disease area
- MIMS Alert - safety alerts and other urgent prescribing updates sent to you as they happen
MIMS editorial process
|Each MIMS product monograph is compiled by our team of pharmacists based on the approved licence information. The monograph is an expert abbreviation of the full summary of product characteristics (SPC) which readers can refer to in full at www.medicines.org.uk
|MIMS is not influenced by marketing information from pharmaceutical companies and all products are included at the discretion of the editorial team. Coverage of new products and other prescribing news is decided solely by the editorial team.
Definitions in MIMS
| P - pharmacy-only medicine
A product that may only be sold in a registered pharmacy under the supervision of a registered pharmacist.
| POM - prescription-only medicine
A product that may only be sold or supplied to the public on a practitioner's prescription.
| GSL - general sales list
A product that may be sold from a retail outlet without the supervision of a registered pharmacist.
| CD - controlled drug
A product that is controlled by the Misuse of Drugs Act 1971 and is listed in schedule 2 or 3 of the Misuse of Drugs Regulations 2001 as amended, which may be subject to specific restrictions relating to supply, prescription, storage, record-keeping, labelling and destruction.
| ACBS - Advisory Committee on Borderline Substances
A product (eg, gluten-free bread) that may be prescribed for the treatment of certain conditions. Prescriptions for these products must be endorsed 'ACBS'.
| NC (no legal class)
A product that may be classed as a device or appliance.
|MIMS provides NHS list prices, which exclude VAT and are not appropriate to quote to patients for private prescriptions or over-the-counter sales.
|Children are not defined by any particular age range in MIMS; the doses and age ranges given are all taken from the approved prescribing information.
|Renal function is reported in MIMS as either creatinine clearance (CrCl) or estimated glomerular filtration rate (eGFR), depending on how it is presented in the drug's SPC.
Creatinine clearance can be calculated using the Cockcroft-Gault equation and is based on the patient's serum creatinine, age, gender and weight; it is given in ml/min.
eGFR is usually calculated using the abbreviated Modification of Diet in Renal Disease (MDRD) formula, which is based on serum creatinine, age, gender and race. It is normalised to a body surface area of 1.73m 2 , and thus given in ml/min/1.73m 2 .
|A list of the abbreviations used in MIMS can be found below and at the front of every print issue.
BPH – benign prostatic hyperplasia
CABG – coronary artery bypass graft
CHF – congestive heart failure
CHM – Commission on Human Medicines
COPD – chronic obstructive pulmonary disease
CrCl – creatinine clearance
CYP – cytochrome P450
DVT – deep vein thrombosis
(e)GFR – (estimated) glomerular filtration rate
GORD – gastro-oesophageal reflux disease
EMA – European Medicines Agency
FBC – full blood count
f-c – film-coated
FSH – follicle-stimulating hormone
hMG – human menopausal gonadotropin
G6PD – glucose-6-phosphate dehydrogenase
GnRH – gonadotropin-releasing hormone
INR – international normalised ratio
IOP – intraocular pressure
iu – international units
LFTs – liver function tests
LH – luteinising hormone
LHRH – luteinising hormone-releasing hormone
LMWH – low molecular weight heparin
LVEF – left ventricular ejection fraction
MAOI – monoamine oxidase inhibitor
MDI – metered dose inhaler
MHRA – Medicines and Healthcare products Regulatory Agency
MI – myocardial infarction
NICE – National Institute for Health and Care Excellence
(N)NRTI – (non)-nucleoside reverse transcriptase inhibitor
NSTEMI – non-ST-segment elevation myocardial infarction
NYHA – New York Heart Association
PCI – percutaneous coronary intervention
PDE5 – phosphodiesterase type 5
P-gp – P-glycoprotein
PPI – proton pump inhibitor
PSA – prostate-specific antigen
PT – prothrombin time
RTI – respiratory tract infection
s-c – sugar-coated
SIADH – syndrome of inappropriate secretion of antidiuretic hormone
SNRI – serotonin-noradrenaline reuptake inhibitor
SPC – Summary of Product Characteristics (available on eMC at www.medicines.org.uk)
SSRI – selective serotonin reuptake inhibitor
SSTI – skin and soft tissue infection
STEMI – ST-segment elevation myocardial infarction
sust-release – sustained-release
TCAD – tricyclic antidepressant
TIA – transient ischaemic attack
ULN – upper limit of normal
UTI – urinary tract infection
VTE – venous thromboembolism
wbc – white blood cells
WFI – water for injections
Z-E syndrome – Zollinger-Ellison syndrome
|Because of space constraints in the print edition of MIMS, some products (eg, cancer drugs, woundcare products and anaesthetics) are listed online only. For some products that are included in the print edition (eg, HIV drugs), readers may be referred to mims.co.uk for the full MIMS listings.
|For space reasons, the MIMS visual guides are no longer included in the print edition of MIMS.
GPs and MIMS subscribers can access the visual guide to diabetes devices online.
To receive a printed copy of the MIMS for Nurses Visual Guide to Respiratory Devices sponsored by Teva UK Ltd, please email firstname.lastname@example.org with your name and practice address.
Submitting information to MIMS
|Please send details of the new product (SPC/product information sheet and NHS list prices for all available pack sizes) or product change to email@example.com and the editorial team will evaluate it for inclusion in MIMS. Please note the deadline for inclusion in a particular quarterly print issue is generally the last working day of the month two months before (ie, around 31st January for the March issue).
Listing in MIMS is solely at the editorial team's discretion and carries no charge.
|The MIMS editorial team welcomes suggestions from GPs and other users about how we can best support prescribing in primary care. Please email firstname.lastname@example.org .
|GPs working in the UK and based in an NHS practice can request a free subscription to MIMS, including full online access and quarterly print copies of MIMS, by completing our simple registration form.
|Unfortunately we are no longer able to deliver free copies of MIMS to a home address. GP locums can access MIMS for free online and in print at special subscription rates.
Subscribe at GP locum rates
|MIMS is available free online to nurses, upon registration. You can register here. To access MIMS in print, please take out a subscription at a special nurses rate.
Subscribe at nurse rates
|Members of UKMi receive free access to MIMS online. For login details, please contact your local UKMi representative. MIMS also offers C+D subscribers a chance to access MIMS with a 15% discount.
Find out more about MIMS for C+D subscribers
|We offer a variety of corporate subscriptions tailored to your business needs, whether online licences or multi-user print and online subscriptions.
If you would like access for 5 or more users at your company we can offer substantial discounts on subscription rates. Contact Alice French, Subscriptions Marketing Manager, on 020 8267 4865 or email@example.com .
MIMS delivery issues
|The print edition of MIMS is usually distributed in the first week of March, June, September and December. Delivery may occasionally be delayed by postal issues. If you haven't received your copy by the middle of the month, please contact firstname.lastname@example.org (if you are a GP) or email@example.com (if you are a subscriber).
Obtaining single issues of MIMS
|Single copies of the current issue are available at a cost of £20. To purchase, email firstname.lastname@example.org or call +44 (0)1604 828702
|We are unable to send out sample copies of MIMS but you can view content from a recent print issue on our 'About us' page.
|We regret we are unable to send out old editions of MIMS as these contain out-of-date prescribing information. If you have a specific query or information requirement, please email email@example.com and we may be able to assist you.
|MIMS offers an app for iPhone, iPad and Android that provides access to MIMS drug data and reference tables on the go (no internet access needed).
Find out more about the MIMS app
MIMS education and events
|MIMS offers several opportunities to help GPs meet their appraisal and revalidation requirements.
MIMS Learning Live is an established clinical conference providing high-quality education designed to meet GPs’ specific learning needs, worth at least 5.5 hours CPD per event.
MIMS Learning is an educational website for GPs offering over 400 learning activities on a wide variety of clinical topics, along with pre-prepared learning plans and an integrated CPD organiser.
MIMS Learning Essentials is the go-to resource for keeping up to date with all the latest clinical guidance relevant to general practice. The MIMS Essentials Syllabus provides constantly updated online learning and the one-day MIMS Essentials Events offer one-day practical updates worth a minimum of 6 CPD credits.
|Our popular and highly regarded MIMS clinical conferences, including MIMS Learning Live and MIMS Learning Essentials , are tailored specifically to GPs' needs. Engaging expert speakers focus on issues highly relevant to general practice, to help you tackle the clinical challenges you face every day. Attendance can make a valuable contribution to your CPD requirements.
Contact firstname.lastname@example.org for more information.
|The MIMS drug database can be licensed out to third party suppliers at the discretion of the MIMS team. We are able to supply the database via API feed either in its entirety or as a selection of fields. Licensing costs are based on user base or similar, and we will work with you to put together a bespoke information package that meets your needs. If you're interested in licensing MIMS content for your product or service, contact Alice French on 020 8267 4865 or email@example.com .